Back to New Hampshire

SB544 • 2026

(New Title) relative to managed care laws.

(New Title) relative to managed care laws.

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Donovan Fenton (D), Cindy Rosenwald (D), Karel Crawford (R), Pat Long (D), Mark Pearson (R), Lisa Mazur (R), Regina Birdsell (R)
Last action
2026-07-09
Official status
SIGNED BY GOVERNOR
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

(New Title) relative to managed care laws.

(New Title) relative to managed care laws.

What This Bill Does

  • (New Title) relative to managed care laws.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

Amendment #2026-1703h : AA VV 05/14/2026 HJ 13

Plain English: Amendment #2026-1703h : AA VV 05/14/2026 HJ 13 1

  • The official amendment file could not be read automatically during the last sync, so only the official amendment metadata is shown right now.

Bill History

  1. 2026-07-09 S

    Signed by the Governor on 07/02/2026; Chapter 263; Effective 01/01/2027

  2. 2026-06-17 H

    Enrolled (in recess of) 06/04/2026 HJ 15

  3. 2026-06-17 S

    Enrolled Adopted, VV, (In recess 06/04/2026); SJ 14

  4. 2026-05-21 S

    Sen. Rochefort Moved to Concur with the House Amendment, MA, VV; 05/21/2026; SJ 13

  5. 2026-05-14 H

    Amendment #2026-1703h : AA VV 05/14/2026 HJ 13

  6. 2026-05-14 H

    Ought to Pass with Amendment 2026-1703h: MA VV 05/14/2026 HJ 13

  7. 2026-05-01 H

    Committee Report: Ought to Pass with Amendment #2026-1703h 04/29/2026 (Vote 15-0; CC) HC 19 P. 7

  8. 2026-04-22 H

    Subcommittee Work Session: 04/28/2026 10:00 am GP 229

  9. 2026-04-22 H

    Executive Session: 04/29/2026 10:00 am GP 229

  10. 2026-04-16 H

    Subcommittee Work Session: 04/22/2026 10:00 am GP 229

  11. 2026-04-09 H

    Public Hearing: 04/15/2026 11:30 am GP 229

  12. 2026-03-16 H

    Introduced (in recess of) 03/12/2026 and referred to Commerce and Consumer Affairs HJ 8 P. 114

  13. 2026-03-06 S

    Committee Amendment #2026-1038s , AA, VV; 03/12/2026; SJ 6

  14. 2026-03-06 S

    Ought to Pass with Amendment #2026-1038s , MA, VV; OT3rdg; 03/12/2026; SJ 6

  15. 2026-03-04 S

    Committee Report: Ought to Pass with Amendment #2026-1038s , 03/12/2026; Vote 4-1; CC; SC 9

  16. 2026-01-28 S

    Hearing: 02/04/2026, Room 100, SH, 09:00 am; SC 4

  17. 2025-11-24 S

    Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1

Official Summary Text

(New Title) relative to managed care laws.

Current Bill Text

Read the full stored bill text
CHAPTER 263
SB 544-FN - FINAL VERSION

03/12/2026 1038s
14May2026... 1703h
2026 SESSION
26-2160
05/09

SENATE BILL
544-FN

AN ACT
relative to managed care laws.

SPONSORS: Sen. Fenton, Dist 10; Sen. Long, Dist 20; Sen. Birdsell, Dist 19; Sen. Rosenwald, Dist 13; Rep. M. Pearson, Rock. 34; Rep. Crawford, Carr. 3; Rep. Mazur, Hills. 44

COMMITTEE: Health and Human Services

─────────────────────────────────────────────────────────────────

AMENDED ANALYSIS

This bill amends pharmacy benefits manager reporting and examination requirements.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in
bold italics.
Matter removed from current law appears [
in brackets and struckthrough.
]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
03/12/2026 1038s
14May2026... 1703h 26-2160
05/09

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty-Six

AN ACT
relative to managed care laws.

Be it Enacted by the Senate and House of Representatives in General Court convened:

263:1 Managed Care Law; Prescription Drugs. Amend RSA 420-J:7-b, III-IV to read as follows:
III. Every health plan that provides prescription drug benefits shall provide written notice in a conspicuous font and size to covered persons affected by deletions to the plan list or plan formulary, provide an explanation of the exception process by which a covered person can access nonformulary medically necessary prescription drugs, and provide a toll-free telephone number through which a covered person can request additional information. For purposes of this paragraph, covered persons affected by deletions to the plan list or plan formulary shall include those covered persons for whom the health plan has provided coverage for the deleted prescription drugs during the 12-month period immediately prior to the deletion. Upon notification to covered persons, the health benefit plan shall allow at least [
45
]
60
days before implementation of any formulary deletions; provided, however, that advance notice shall not be required if the federal Food and Drug Administration has determined that a prescription drug on the health benefit plan's formulary is unsafe. For purposes of this section, "conspicuous font and size" shall mean a font that is at least [
12
]
14
point in size and in an easily legible font. If a covered person avails himself or herself of the exception process as outlined in 420-J:7-b, II, the medication shall be covered by the health plan until there is a resolution of the exception process.
Any denial of an exceptions request shall be considered an adverse determination.
IV. Every health benefit plan that provides prescription drug benefits shall maintain, as part of its records, all of the following information, which shall be made available to the commissioner upon request:

(a)
[
the
]
The
complete drug formulary or formularies of the plan, if the plan maintains a formulary, including a list of the prescription drugs on the formulary of the plan by major therapeutic category with an indication of whether any drugs are preferred over the other drugs.

(b) Documentation regarding any changes to the formulary including the date the formulary was changed and the reason for the change.
(c) The complete maximum allowable cost list for each pharmacy subject to the maximum allowable cost list.
(d) Documentation regarding any changes to the maximum allowable cost list including, but not limited to, the date the maximum allowable cost list was changed and when impacted pharmacies were notified of the change.

263:2 Effective Date. This act shall take effect January 1, 2027.

Approved: July 02, 2026
Effective Date: January 01, 2027